Marjorie Golden

Marjorie Golden

Auto-generated profile, based on publicly available information

Marjorie Golden

Department of Epidemiology of Microbial Diseases, Yale School of Public Health and Yale School of Medicine , New Haven, Connecticut

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in Arthroplasty Today
Verified
Journal Article
Open access
NPNeil Pathak
Neil Pathak
PBPat Bovonratwet
Pat Bovonratwet
JPJames J. Purtill
James J. Purtill
JBJenna A. Bernstein
Jenna A. Bernstein
MGMarjorie Golden
Marjorie Golden
LRLee E Rubin
Lee E Rubin
Studies analyzing the incidence and clinical implications of postoperative hematomas after total hip arthroplasty (THA) remain limited. The purpose of the present study was to use the National Surgical Quality Improvement Program (NSQIP) dataset to determine rates, risk factors, and subsequent complications of postoperative hematomas requiring reoperation after primary THA. Study population included patients who underwent primary THA (CPT code: 27130) from 2012-2016 recorded in NSQIP. Patients who developed a hematoma requiring reoperation in the 30-day postoperative period were identified. Multivariate regressions were created to identify patient characteristics, operative variables, and subsequent complications that were associated with a postoperative hematoma requiring reoperation. Among the 149,026 patients who underwent primary THA, 180 (0.12%) developed a postoperative hematoma requiring reoperation. Risk factors included body mass index (BMI) ≥ 35 (relative risk [RR]: 1.83, P = .011), American Society of Anesthesiologists (ASA) class ≥3 (RR: 2.11, P < .001), and history of bleeding disorder (RR: 2.71, P < .001). Associated intraoperative characteristics were an operative time ≥100 minutes (RR: 2.03, P < .001) and use of general anesthesia (RR: 1.41, P = .028). Patients developing a hematoma requiring reoperation were at higher risk of subsequent deep wound infection (RR: 21.57, P < .001), sepsis (RR: 4.3, P = .012), and pneumonia (RR: 3.69, P = .023). Surgical evacuation for a postoperative hematoma was performed in about 1 in 833 cases of primary THA. Several nonmodifiable and modifiable risk factors were identified. Given the 21.6 times increased risk of subsequent deep wound infection, select, at-risk patients may benefit from closer monitoring for signs of infection.

17 March 2022 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
MGMarjorie Golden
Marjorie Golden
AMAnne Spichler Moffarah
Anne Spichler Moffarah
CKChristopher Kerantzas
Christopher Kerantzas
LRLee Rubin
Lee Rubin
JOJane O’bRyan
Jane O’bRyan
Accurate diagnosis ensures appropriate therapy of periprosthetic joint infection (PJI). Since mycobacterial PJI is rare, routine testing is inappropriate. We reviewed hip and knee PJI at our institution over 28 months. Mycobacterial cultures were routinely sent with rare positivity. Mycobacterial cultures should be sent only when there is clinical suspicion.

30 October 2024 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
PDF file
TBThilinie Dulanjalee Bandaranayake
Thilinie Dulanjalee Bandaranayake
CRChristopher Radcliffe
Christopher Radcliffe
MCMelanie Cvercko
Melanie Cvercko
MGMarjorie Golden
Marjorie Golden
RHRitche Manos Hao
Ritche Manos Hao
Background: Oritavancin is a lipoglycopeptide antibacterial agent used to treat infections caused by Gram-positive organisms. It is FDA-approved for the treatment of acute bacterial skin and soft tissue infections (ABSSIs) but is increasingly being used off-label to treat invasive bacterial infections such as osteomyelitis, prosthetic joint infection and infective endocarditis. Objectives: This study describes the clinical outcomes and adverse reactions related to oritavancin. Patients and methods: This was a retrospective study conducted over a 5 year period at a tertiary care medical centre. Ninety-five adult patients were included in this study and were followed for 1 year after the last dose of oritavancin. Results: The most common indication for oritavancin at our institution was osteomyelitis, followed by ABSSI. Other indications were vertebral infection, hardware-associated infection, bacteraemia and infective endocarditis. Fourteen percent (13/95) of patients developed an adverse reaction to oritavancin during the study period. Cure with no recurrence up to 1 year after the last dose of oritavancin was achieved in 74% (53/71) of patients, and the treatment failure rate was 19% (14/71 patients). Conclusions: Oritavancin is an effective agent that can be used to treat invasive Gram-positive bacterial infections other than ABSSI. Adverse events requiring drug discontinuation were common.

28 May 2021 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JCJoseph E Canterino
Joseph E Canterino
KWKaicheng Wang
Kaicheng Wang
MGMarjorie Golden
Marjorie Golden
During the coronavirus disease 2019 (COVID-19) pandemic, our institution transitioned infectious diseases (ID) consultations on hospitalized patients to telemedicine. We evaluated satisfaction with telemedicine among referring providers and ID consultants. Respondents were satisfied with telemedicine consults for hospitalized patients, although there were significant differences in perceptions of quality and timeliness between consultants and referring providers.

27 March 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
ASAnne Spichler
Anne Spichler
LDLauren Daddi
Lauren Daddi
DNDuc Nguyen
Duc Nguyen
IMIlda Molloy
Ilda Molloy
MGMarjorie Golden
Marjorie Golden
There is no consensus on diagnostic criteria for hip and knee periprosthetic joint infections (PJIs). This study evaluated Infectious Diseases Society of America (IDSA), International Consensus Meeting 2018 (ICM2018), and European Bone and Joint Society (EBJIS) criteria, finding IDSA most accurate for early PJI and knee infections, while ICM2018 and EBJIS were superior for delayed and late cases. Diagnostic approaches should consider infection timing and context.

3 June 2026 in Journal of Bone and Joint Infection
Verified
Journal Article
Open access
PDF file
ASAnne Spichler
Anne Spichler
LDLauren Daddi
Lauren Daddi
IMIlda Molloy
Ilda Molloy
TLTyler Luu
Tyler Luu
DNDuc Nguyen
Duc Nguyen
MGMarjorie Golden
Marjorie Golden
Background: Discrepancies exist between preoperative synovial aspirations and intraoperative cultures. It is unclear whether the results of preoperative arthrocentesis add diagnostic value for patients with possible prosthetic joint infection (PJI). Methods: We retrospectively identified adult patients treated surgically for hip and knee PJI who underwent both preoperative aspiration and intraoperative sampling. Synovial and intraoperative culture results were analyzed. Cultures were defined as concordant if they yielded the same organism(s) or if both were negative. Cultures were considered to be discordant if different organisms were isolated or if one had growth and the other was sterile. Demographic, clinical, and laboratory variables between groups were compared. Results: Among 75 patients, 54 (72 %) had concordant results, and 21 (28 %) had discordant results. In the discordant group, 7 of 21 patients (33 %) had negative synovial cultures with positive intraoperative cultures. Among culture-positive concordant patients, staphylococci and streptococci were the most common isolates, with 20 % gram negatives. True culture-negative PJI was uncommon (n=1). Preoperative antibiotic exposure was frequent (>50 %) in both groups. Conclusion: In a cohort of hip and knee PJI patients treated surgically, preoperative synovial aspiration cultures were concordant with intraoperative cultures in 72 % of cases, but negative synovial aspirations did not reliably exclude infection. Given the observed discordance, our findings support the obtainment of preoperative synovial aspiration and the collection of multiple intraoperative specimens at the time of surgery.